Streptococcosis and motile Aeromonad septicemia (MAS) are the main bacterial diseases in tilapia culture worldwide, causing significant economic losses. Vaccination is an effective method of preventing diseases and contributes to economic sustainability. This study investigated the immuno-protective efficacy of a newly developed feed-based bivalent vaccine against streptococcosis and MAS in red hybrid tilapia.
View Article and Find Full Text PDFThe genus has been recognised as an important pathogenic species in aquaculture that causes motile septicaemia (MAS) or less severe, chronic infections. This study compares the pathogenicity of the different spp. that were previously isolated from freshwater fish with signs of MAS.
View Article and Find Full Text PDF